Q-Line Biotech Schedules Board Meeting on 12th Nov'26 to Approve H1 Financial Results
Q-Line Biotech Ltd 路 Others (Uncategorized) 路 06 Nov 2026, 12:40 am
Q-Line Biotech Schedules Board Meeting on 12th Nov'26 to Approve H1 Financial Results Q-Line Biotech Limited has scheduled its Board of Directors meeting on 12th Nov'26 at 04:15 p.m. to consider and approve the unaudited standalone and consolidated financial results, Statement of Assets and Liabilities, and Cash Flow statement for the half-year ended 30th Sep'26, along with the Statutory Auditor's Limited Review Reports. The company also issued a clarification confirming the meeting will occur at 4:15 p.m., rectifying an inadvertent clerical error that previously stated 3:00 p.m. in the subject line.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. 路 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Investor Presentation 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about General Updates 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "PRESS RELEASE ON FINANCIAL RESULTS 30 SEPTEMBER 2026.". 路 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
